Skip to main content

Table 5 Clinical phenotypes of LDLR, APOB, PCSK9 and LDLRAP1 gene mutations

From: Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction

Case

Gene

Function

Exon

Sites of the Mutation

LDL-C (mmol/L)

Gensini Scores

Case1

LDLR

Missense

3

c.241C > T

4.86

40

Case2

LDLR

Missense

3

c.292G > A

3.89

48

Case3

LDLR

Missense

10

c.1525A > G

8.00

54

Case4

LDLR

Missense

11

c.1691A > G

4.35

128

Case5

LDLR

Missense

11

c.1691A > G

7.25

100

Case6

LDLR

Missense

13

c.1867A > T

5.72

104

Case7

LDLR

Missense

14

c.2054C > T

7.74

78

Case8

LDLR

Missense

14

c.2054C > T

6.37

157

Case9

APOB

Missense

26

c.10579C > T

4.93

57

Case10

PCSK9

Missense

2

c.277C > T

3.26

40

Case11

PCSK9

Missense

2

c.277C > T

2.68

40

Case12

PCSK9

Missense

2

c.277C > T

1.66

168

Case13

PCSK9

Missense

2

c.277C > T

3.46

12

Case14

PCSK9

Missense

2

c.277C > T

3.02

65

Case15

PCSK9

Missense

3

c.1792G > A

3.60

117

Case16

LDLRAP1

Missense

1

c.65G > C

2.66

54

Case17

LDLR+PCSK9+LDLRAP1

   

2.50

62

  1. LDLR low-density lipoprotein receptor, APOB apolipoprotein B, PCSK9 proprotein convertase subtilisin/kexin type 9, LDLRAP1 low-density lipoprotein receptor adaptor protein 1